Quest Diagnostics, one of the largest clinical laboratories in the U.S., started offering BRCA testing this week as it seeks to tap into the lucrative breast cancer genetic testing market. But Quest and other companies that plan to offer less-expensive testing still face legal battles with the... FULL STORY »
In an unusual collaboration, laboratory services provider Quest Diagnostics is opening up its database of lab results to work with the Centers for Disease Control and Prevention on a research program on hepatitis C focused on baby boomers, whose members account for roughly two-thirds of the 3.2... FULL STORY »
Hours after the U.S. Supreme Court invalidated Myriad Genetics' monopoly on testing for two breast cancer genes, the company's stock went tumbling as competitors announced plans to offer the same services at lower prices. FULL STORY »
Just hours after the U.S. Supreme Court invalidated Myriad Genetics' monopoly on testing for two breast cancer genes, the company's stock went tumbling as competitors announced plans to offer the same services at lower prices. FULL STORY »
Quest Diagnostics, a Madison, N.J.-based provider of diagnostic information services, has acquired medical center operator Concentra's toxicology and clinical laboratory business and agreed to serve as Concentra's primary provider of workplace drug toxicology and clinical laboratory testing. FULL STORY »
By Judy Greenwald, Business Insurance | May 09, 2013
Quest Diagnostics Inc. will pay a $70,000 penalty and no longer automatically disqualify job applicants with prior arrests or criminal convictions as part of a settlement agreement with the New York attorney general's office. FULL STORY »
Jim Davis is the new senior VP of diagnostic solutions for Madison, N.J.-based Quest Diagnostics. Davis will oversee Quest's diagnostic products, insurer services, clinical trials, health information technology and employer solutions. FULL STORY »
The U.S. Supreme Court will hear oral arguments this week in the Myriad Genetics gene patenting case, whose outcome could have major financial consequences for healthcare providers and patients and help determine the future affordability of gene-based medical technologies and personalized medicine. FULL STORY »
By Joseph Conn and Melanie Evans | January 07, 2013
| Basic Web
Athenahealth, a health information technology company, announced its second acquisition agreement since September with a $293 million cash deal for Epocrates, a mobile application developer. FULL STORY »
Switch to the new Modern Healthcare Daily News app
For the best experience of ModernHealthcare.com on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.
